DK38984A - Pyridazinderivater, som i 3-stillingen er substitueret med amino, og som indvirker paa centralnervesystemet, fremgangsmaade til fremstilling heraf og laegemidler med indhold heraf - Google Patents

Pyridazinderivater, som i 3-stillingen er substitueret med amino, og som indvirker paa centralnervesystemet, fremgangsmaade til fremstilling heraf og laegemidler med indhold heraf Download PDF

Info

Publication number
DK38984A
DK38984A DK38984A DK38984A DK38984A DK 38984 A DK38984 A DK 38984A DK 38984 A DK38984 A DK 38984A DK 38984 A DK38984 A DK 38984A DK 38984 A DK38984 A DK 38984A
Authority
DK
Denmark
Prior art keywords
procedures
amino
impact
preparing
nervous system
Prior art date
Application number
DK38984A
Other languages
English (en)
Other versions
DK162985C (da
DK162985B (da
DK38984D0 (da
Inventor
Jean-Pierre Chambon
Kathleen Biziere
Camille-Georges Wermuth
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of DK38984D0 publication Critical patent/DK38984D0/da
Publication of DK38984A publication Critical patent/DK38984A/da
Publication of DK162985B publication Critical patent/DK162985B/da
Application granted granted Critical
Publication of DK162985C publication Critical patent/DK162985C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK038984A 1983-01-27 1984-01-27 Pyridazinderivater, som i 3-stillingen er substitueret med amino, og som indvirker paa centralnervesystemet, fremgangsmaade til fremstilling heraf og laegemidler med indhold heraf DK162985C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8301234 1983-01-27
FR8301234A FR2540113A1 (fr) 1983-01-27 1983-01-27 Acides derives de la pyridazine actifs sur le systeme nerveux central

Publications (4)

Publication Number Publication Date
DK38984D0 DK38984D0 (da) 1984-01-27
DK38984A true DK38984A (da) 1984-07-28
DK162985B DK162985B (da) 1992-01-06
DK162985C DK162985C (da) 1992-06-01

Family

ID=9285330

Family Applications (1)

Application Number Title Priority Date Filing Date
DK038984A DK162985C (da) 1983-01-27 1984-01-27 Pyridazinderivater, som i 3-stillingen er substitueret med amino, og som indvirker paa centralnervesystemet, fremgangsmaade til fremstilling heraf og laegemidler med indhold heraf

Country Status (27)

Country Link
US (1) US4721711A (da)
EP (1) EP0117779B1 (da)
JP (1) JPS59141564A (da)
KR (1) KR910000638B1 (da)
AR (1) AR240045A1 (da)
AT (1) ATE48417T1 (da)
AU (2) AU2372984A (da)
CA (1) CA1238637A (da)
DD (1) DD220026A5 (da)
DE (1) DE3480653D1 (da)
DK (1) DK162985C (da)
ES (1) ES529081A0 (da)
FI (1) FI78691C (da)
FR (1) FR2540113A1 (da)
HU (1) HU193890B (da)
IE (1) IE57054B1 (da)
IL (1) IL70756A (da)
MA (1) MA20018A1 (da)
NO (1) NO840313L (da)
NZ (1) NZ206945A (da)
OA (1) OA07644A (da)
PH (1) PH21162A (da)
PL (1) PL142340B1 (da)
PT (1) PT77993B (da)
SG (1) SG93690G (da)
YU (1) YU14284A (da)
ZA (1) ZA84502B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
DE3664772D1 (en) * 1985-01-14 1989-09-07 Boehringer Ingelheim Kg 12-amino pyridazinoû4',5':3,4¨pyrroloû2,1-a¨isoquinolines, process for their preparation and use
US5082939A (en) * 1987-01-08 1992-01-21 I.S.F. Societa Per Azioni Pyridazine derivatives
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
FR2663326B2 (fr) * 1989-11-17 1992-10-16 Sanofi Sa Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
US5631255A (en) * 1989-02-07 1997-05-20 Sanofi Pyridazine derivatives
FR2668151A1 (fr) * 1990-10-23 1992-04-24 Rhone Poulenc Agrochimie Composes a groupe triazolopyridazine leurs preparations et compositions herbicides les contenant.
FR2676444B1 (fr) * 1991-05-16 1995-03-10 Sanofi Elf Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.
CN1038249C (zh) * 1991-08-28 1998-05-06 罗姆和哈斯公司 含有二氢哒嗪酮及其相关化合物的杀菌组合物
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
EP2264014A1 (en) * 2001-08-31 2010-12-22 Université Louis Pasteur Substituted pyridazines as anti-inflammatory agents and protein kinase inhibitors
JP2008518955A (ja) * 2004-11-02 2008-06-05 ノースウェスタン ユニバーシティ ピリダジン化合物および方法
CA2589106C (en) 2004-11-02 2015-07-21 Northwestern University Pyridazine compounds, compositions and methods and their use in treating inflammatory diseases
US20100168120A1 (en) * 2006-04-28 2010-07-01 Neuromedix Inc. Salts of pyridazine compounds
US8158627B2 (en) * 2006-04-28 2012-04-17 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
AU2007243280A1 (en) * 2006-04-28 2007-11-08 Northwestern University Formulations containing pyridazine compounds for treating neuroinflammatory diseases
EP2142498A2 (en) * 2007-04-02 2010-01-13 Institute for Oneworld Health Cftr inhibitor compounds and uses thereof
WO2009131957A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising oxadiazole derivatives
US8236838B2 (en) * 2008-04-21 2012-08-07 Institute For Oneworld Health Compounds, compositions and methods comprising isoxazole derivatives
US20090264433A1 (en) * 2008-04-21 2009-10-22 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Triazine Derivatives
US20090270398A1 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Pyridazine Derivatives
JP2012503005A (ja) * 2008-09-19 2012-02-02 インスティテュート フォア ワンワールド ヘルス イミダゾール誘導体およびトリアゾール誘導体を含む、化合物、組成物ならびに方法。
US20100267706A1 (en) * 2009-04-20 2010-10-21 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Pyridazine Derivatives
US8343976B2 (en) * 2009-04-20 2013-01-01 Institute For Oneworld Health Compounds, compositions and methods comprising pyrazole derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510998B1 (fr) * 1981-08-07 1986-01-10 Sanofi Sa Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
CA1218655A (en) * 1983-01-28 1987-03-03 Kathleen Biziere Process for the preparation of pyridazine derivatives having a psychotropic action

Also Published As

Publication number Publication date
FR2540113B1 (da) 1985-05-17
KR910000638B1 (ko) 1991-01-31
US4721711A (en) 1988-01-26
PL245931A1 (en) 1985-07-16
YU14284A (en) 1986-12-31
FI840323L (fi) 1984-07-28
MA20018A1 (fr) 1984-10-01
ATE48417T1 (de) 1989-12-15
AU2372984A (en) 1984-08-02
DK162985C (da) 1992-06-01
AU2142188A (en) 1989-03-16
NO840313L (no) 1984-07-30
PH21162A (en) 1987-08-05
JPS59141564A (ja) 1984-08-14
EP0117779A1 (fr) 1984-09-05
AU652118B2 (en) 1994-08-18
CA1238637A (en) 1988-06-28
ZA84502B (en) 1984-09-26
FI840323A0 (fi) 1984-01-26
IE57054B1 (en) 1992-04-08
AR240045A1 (es) 1990-01-31
IE840149L (en) 1984-07-27
DK162985B (da) 1992-01-06
KR840007586A (ko) 1984-12-08
EP0117779B1 (fr) 1989-12-06
IL70756A (en) 1987-03-31
FR2540113A1 (fr) 1984-08-03
HU193890B (en) 1987-12-28
PT77993A (fr) 1984-02-01
FI78691C (fi) 1989-09-11
OA07644A (fr) 1985-05-23
IL70756A0 (en) 1984-04-30
ES8500243A1 (es) 1984-10-01
DK38984D0 (da) 1984-01-27
PT77993B (fr) 1986-04-10
SG93690G (en) 1991-01-18
NZ206945A (en) 1987-07-31
DE3480653D1 (de) 1990-01-11
DD220026A5 (de) 1985-03-20
ES529081A0 (es) 1984-10-01
PL142340B1 (en) 1987-10-31
FI78691B (fi) 1989-05-31

Similar Documents

Publication Publication Date Title
DK38984A (da) Pyridazinderivater, som i 3-stillingen er substitueret med amino, og som indvirker paa centralnervesystemet, fremgangsmaade til fremstilling heraf og laegemidler med indhold heraf
DK163988C (da) 9alfa,11alfa-epoxy-20-spiroxaner og analoge deraf med aaben tetrahydrofuranring e samt deres fremstilling og farmaceutiske praeparater indeholdende dem
FI922235A7 (fi) Menetelmä keskushermostojärjestelmään vaikuttavien 3-aminopyridatsiinijohdannaisten valmistamiseksi
DK210483D0 (da) Pyrogallolderivater, deres anvendelse og fremgangsmade til fremstilling deraf
NO863765L (no) Arylmetylazoler og salter derav samt fremgangsmaate til fremstilling derav.
NO165639C (no) Oksalkylerte polyesteraminer, fremgangsmaate til deres fremstilling, og deres anvendelse.
DK418684D0 (da) Farmaceutiske midler indeholdende pyridazinonderivater, fremgangsmaade til fremstilling heraf samt mellemprodukter derfor
NO822796L (no) Aminoorganoaminosilaner, fremgangsmaate til deres fremstilling og deres anvendelse
DK170788D0 (da) Dihydropyridazinonderivater, fremgangsmaader til fremstilling heraf samt laegemidler indeholdende disse
DK361288D0 (da) Hydroxyethylazolylderivater, deres fremstilling og anvendelse samt mellemprodukter til fremstilling og disses fremstilling
DK581183A (da) 2-azabicyclo(2.2.1)heptan-derivater, fremgangsmaader til deres fremstilling, midler indeholdende disse derivater og deres anvendelse, samt 2-azabicyclo(2.2.1)heptan-derivater som mellemprodukter samt fremgangsmaader til deres fremstilling
DK136784D0 (da) Pyrazolo(1,5-a)pyridinderivater samt fremgangsmaade til fremstilling deraf
NO890330L (no) Fremgangsmaate til fremstilling av forbindelser med psykotrop virkning.
DE3677256D1 (de) Polarisationsselektiver reflektor und verfahren zu dessen herstellung.
NO905030D0 (no) Ekstrudert poroes struktur, samt fremgangsmaate og apparat for fremstilling av strukturen.
DK136684D0 (da) Pyrazolo(1,5-a)pyridinderivater samt fremgangsmaade til fremstilling deraf
DK247884D0 (da) Substituerede tetrahydrothiopyran-3,5-dion-4-carboxamider,fremgangsmaade til deres fremstilling og deres anvendelse samt mellemprodukter til fremstillingen
DK624288D0 (da) 3-substituerede pyridiner, fremgangsmaader til deres fremstilling samt deres anvendelse
NO881554D0 (no) Fremgangsmaate for fremstilling av 1-((1,1-difenyl)-1-alkenyl)- piperazin med virkning paa sentralnervesystemet.
DK393282A (da) Anilino-1,2,3-triazol-derivater, fremgangsmaade til deres fremstilling samt deres anvendelse
NO923592L (no) Polyhydroksycyklopentanderivat og fremgangsmaate til fremstilling derav, samt mikroorganisme som er anvendelig i fremgangsmaaten
ES272802Y (es) Soporte expositor para relojes, perfeccionado.
ES1004494Y (es) Gafa perfeccionada para canalones y similares.
NO913297L (no) Nye beta-karboliner, fremgangsmaate for deres fremstilling og anvendelse derav i legemidler.
ES282083Y (es) Montura perfeccionada para gafas.